Bionime Corporation
USPTO PatentsView assignee record - 71 granted patents across 17 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Bionime ranks #4,867 of 49,997 tracked US assignees by granted-patent volume, with 71 patents across 17 technology areas.
- #4,867
- of 49,997 US assignees by volume
- Top 6%
- by Innovation Score (56.3/100)
- 11.6
- avg claims per patent
- +193%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R4867 · Foreign Corporation #4,867 · 71 grants
GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-SMALL 71 grants
- TOP-DECILE #4,867/49,997
- PHOTO-FINISH Avinger
- CPC-FOCUS A61B · 17 areas
- INNOV-PAR 56.3/100
- CLAIMS-PAR 11.6 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +193% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Avinger, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Bionime’s 56.3 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Bionime
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Armaments Research · near
Armaments Research · near
56 score
- Asml Holding · near
Asml Holding · near
56 score
- Bionime · this assignee
Bionime · this assignee
56 score
- Holtec International · near
Holtec International · near
56 score
- Soliton · near
Soliton · near
56 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Bionime's Innovation Score is 56.3/100 (top 6% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Bionime?
Each dot is one of Bionime’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Bionime’s own 11.6 claims/patent is at or below the 11.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Bionime's grants concentrate
Bionime Corporation is a focused PatentsView assignee: 17 CPC subclasses with 63.4% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2024 (14 grants) versus a trough of 2 in 2017. By volume, Bionime sits between Avinger, Inc. and Changzhou Patent Electronic Technology Co., Ltd.
Bionime's three-year grant acceleration
Bionime Corporation shows 36 grants in 2022–2024 against only 11 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Bionime's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Avinger
Avinger, Inc.
71 patents
- Bandai
Bandai Co. Ltd
71 patents
- Basf Agro B V
Basf Agro B.V.
71 patents
- Beto Engineering…
Beto Engineering & Marketing Co., Ltd.
71 patents
- Bedford Industries
Bedford Industries, Inc.
71 patents
- Blast Motion
Blast Motion Inc.
71 patents
- Bunn-o-matic
Bunn-O-Matic Corporation
71 patents
- Changzhou Patent…
Changzhou Patent Electronic Technology Co., Ltd
71 patents
- Bionime ◀
Bionime Corporation
71 patents
What this shows Bionime holds 71 patents at rank #4,866, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Bionime
By rank, the assignees closest to #4,866 in granted patent volume.
- Avinger, Inc. #4,862 · 71 patents
- Bandai Co. Ltd #4,863 · 71 patents
- Basf Agro B.V. #4,864 · 71 patents
- Beto Engineering & Marketing Co., Ltd. #4,865 · 71 patents
- Bedford Industries, Inc. #4,867 · 71 patents
- Blast Motion Inc. #4,868 · 71 patents
- Bunn-O-Matic Corporation #4,869 · 71 patents
- Changzhou Patent Electronic Technology Co., Ltd #4,870 · 71 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Bionime's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Bionime, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Bionime ranks #425 of 7,127 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (56 here).
Similar claim depth
Nearest assignees by average claims per patent (11.6 here).
Bionime's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
56 Top 6% higher than 94% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 7 | 9.9% |
| 2016 | 3 | 4.2% |
| 2017 | 2 | 2.8% |
| 2019 | 3 | 4.2% |
| 2020 | 4 | 5.6% |
| 2021 | 4 | 5.6% |
| 2022 | 11 | 15.5% |
| 2023 | 11 | 15.5% |
| 2024 | 14 | 19.7% |
| 2025partial year | 12 | 16.9% |
Which technologies does Bionime Corporation patent most?
Top 15 of 17 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Bionime Corporation's patent record in context - here's where to go next.
- Bionime Corporation's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 63.4% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #4,867 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Bionime Corporation against Avinger, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 56.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.